91 related articles for article (PubMed ID: 25471639)
1. Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers.
Bezić J; Šamija Projić I; Projić P; Ljubković J; Zekić Tomaš S; Meljanac Salopek K; Piljić Burazer M; Tomić S
Virchows Arch; 2015 Feb; 466(2):185-9. PubMed ID: 25471639
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.
Pinto AE; André S; Nogueira M; Mendonça E; Soares J
J Clin Pathol; 1997 Jul; 50(7):591-5. PubMed ID: 9306941
[TBL] [Abstract][Full Text] [Related]
3. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
4. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
5. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
9. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
10. Origins and clinical implications of aneuploidy in early bladder cancer.
Shackney SE; Berg G; Simon SR; Cohen J; Amina S; Pommersheim W; Yakulis R; Wang S; Uhl M; Smith CA
Cytometry; 1995 Dec; 22(4):307-16. PubMed ID: 8749781
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer in males: DNA content and sex chromosome constitution.
Wolman SR; Sanford J; Ratner S; Dawson PJ
Mod Pathol; 1995 Apr; 8(3):239-43. PubMed ID: 7617646
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between DNA ploidy and survival in breast cancer].
Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():431-5. PubMed ID: 9589048
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
15. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].
Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H
Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of DNA ploidy in canine mammary tumors.
Rutteman GR; Cornelisse CJ; Dijkshoorn NJ; Poortman J; Misdorp W
Cancer Res; 1988 Jun; 48(12):3411-7. PubMed ID: 3370639
[TBL] [Abstract][Full Text] [Related]
17. [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].
Pinto AE; Pereira T; Silva GL; Ferreira MC; André S
Acta Med Port; 2012; 25(6):399-407. PubMed ID: 23534591
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
20. DNA aneuploidy in early breast cancer.
Ottesen GL; Christensen IJ; Larsen JK; Kerndrup GB; Hansen B; Andersen JA
Br J Cancer; 1995 Oct; 72(4):832-9. PubMed ID: 7547228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
